Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Generic Drugs

MYL:US

31.1750 USD 0.5750 1.81%

As of 16:30:00 ET on 05/24/2013.

Company Profile for Mylan Inc/PA (MYL)

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Contact Information

Mylan Inc/PA

1500 Corporate Drive
Suite 400
Canonsburg, PA 15317
United States
Phone: 1-724-514-1800

Key Executives for Mylan Inc/PA (MYL)

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
Harry A Korman "Hal"Chief Operating OfficerAnthony Mauro "Tony" President:North America
John D SheehanExec VP/CFODaniel C Rizzo JrSenior VP/Chief Acctg Officer
Deborah M. AutorSenior VP:Global QualityKris KingVP:Global Investor Relations
Nina DevlinVP:Corp CommunicationsJoseph F HaggertySecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil